Skip to main content

A case of fatal Guillain–Barre syndrome from anti-PD1 monoclonal antibody use

This is a preview of subscription content, access via your institution.

References

  • Csurhes PA, Sullivan A-A, Green K, Greer JM, Pender MP, McCombe PA (2005) Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndrome. J Clin Neurosci 12(4):409–415

    CAS  Article  PubMed  Google Scholar 

  • Gaudy-Marqueste C, Monestier S, Franques J, Cantais E, Richard M-A, Grob J-J (2013) A severe case of ipilimumab-induced guillain–barré syndrome revealed by an occlusive enteric neuropathy: a differential diagnosis for ipilimumab-induced colitis. J Immunother 36(1):77–78

    Article  PubMed  Google Scholar 

  • Naidoo J, Page D, Li B et al (2015) Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol 26(12):2375–2391

    CAS  PubMed  Google Scholar 

  • Wilgenhof S, Neyns B (2011) Anti-CTLA-4 antibody-induced Guillain–Barré syndrome in a melanoma patient. Ann Oncol 22(4):991–993

    CAS  Article  PubMed  Google Scholar 

  • Yuki N, Hartung H-P (2012) Guillain–Barré syndrome. N Engl J Med 366(24):2294–2304

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Aasems Jacob M.D..

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jacob, A., Unnikrishnan, D.C., Mathew, A. et al. A case of fatal Guillain–Barre syndrome from anti-PD1 monoclonal antibody use. J Cancer Res Clin Oncol 142, 1869–1870 (2016). https://doi.org/10.1007/s00432-016-2191-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-016-2191-7

Keywords

  • Herpes Simplex Virus
  • Plasma Exchange
  • Immune Checkpoint
  • Checkpoint Inhibitor
  • Immune Checkpoint Inhibitor